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Pharmacist-led academic detailing intervention in primary care: A mixed methods 1 
feasibility study 2 
Introduction 3 
The International Continence Society (ICS) has defined urinary incontinence  as “the complaint 4 
of any involuntary leakage of urine” [1]. Despite the availability of evidence-based guidelines, 5 
some patients do not receive recommended treatment because of their reluctance to report this 6 
condition. In addition, when patients do seek help, many physicians are not familiar with the 7 
latest information on the appropriate methods of evaluating and treating patients with this 8 
condition [2]. 9 
Academic detailing is an interactive, convenient, and user-friendly approach that provides non-10 
commercial evidence-based medical information tailored to the needs of an individual. A key 11 
tenant of the intervention is eliciting the provider's beliefs and attitudes and addressing those 12 
specifically during the encounter [3]. Academic detailers (who are usually pharmacists, nurses, 13 
or physicians) are trained to provide accurate, balanced, and up-to-date syntheses of the 14 
evidence on a clinical topic in an engaging format with healthcare professionals in their work 15 
environment [4]. These educational visits appear to be especially effective in improving 16 
prescribing appropriateness in general practice [5]. Other approaches to optimise prescribing 17 
behaviour include a healthcare professional such as a pharmacist carrying out medication 18 
reviews and providing feedback to GPs [6]. Computerised decision support systems (CDSS) 19 
are widely used tools that can support prescribing practice activities. They provide narrative 20 
information usually in the form of an alert at the time of prescribing or at the end of the patient 21 
consultation [7]. However, these approaches have their limitations, for example, there have 22 
been conflicting results reported for medication reviews conducted by pharmacists [8,9]. CDSS 23 
alerts can lead to alert fatigue, cognitive overload and desensitisation raising questions about 24 
the effectiveness of decision support [10]. This suggests that other interventions such as 25 
academic detailing are required to optimise clinical outcomes and patient care. 26 
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To date, no studies have evaluated the feasibility and acceptability of an academic detailing 27 
intervention with General Practitioners (GPs) in Ireland. Prior to implementing an intensive 28 
intervention like academic detailing on a national scale, it is prudent to evaluate the potential 29 
effect in a feasibility study. Eldridge et al. have defined a feasibility study as a study asking 30 
“whether something can be done, should we proceed with it, and if so, how”. They are used to 31 
estimate important parameters that are needed to design larger studies, for example: feasibility 32 
of recruitment, number of eligible participants, and selection of appropriate outcomes [11]. As 33 
the burden of urinary incontinence can impact on the lives of people worldwide (especially 34 
older adults), this would underline why a feasibility study of an academic detailing intervention 35 
is needed.  36 
 37 
Aim of the study 38 
The aim of this study was to assess the feasibility and acceptability to GPs of a pharmacist-led 39 
academic detailing intervention in Ireland. 40 
 41 
Ethics approval 42 
Ethical approval for this study was granted by the clinical research ethics committee of the 43 
Cork University Teaching Hospitals, Cork (reference ECM 4 (s) 10/05/16 & ECM 3 (ddddd) 44 
07/03/17) and the Mallow Primary Health Centre (MPHC), Cork Ethics Committee. Informed 45 





Study type 49 
In this study a convergent parallel mixed methods design was used. This involves the separate 50 
collection and analysis of quantitative and qualitative data with the intent of merging the results 51 
of both analyses. The premise of a mixed methods approach is that the use of quantitative and 52 
qualitative methods in combination provides a better understanding of research problems than 53 
either approach alone [12]. The aim was to collect, analyse, and interpret integrated quantitative 54 
and qualitative data to assess the feasibility to GPs of an academic detailing intervention in 55 
primary care. The quantitative prescribing patterns of the GPs and their qualitative responses 56 
from the focus groups were integrated and synthesised.   57 
Setting 58 
This study was carried out in six General Practices in County Cork, Ireland. The primary 59 
researcher (D.O.R.) arranged a meeting with the lead GP in each practice, and a brief summary 60 
of the study was given. Other potential participants in each practice were contacted by 61 
telephone and invited to participate. Twenty-three GPs participated in the intervention.  All 62 
GPs who participated in the study received a certificate of participation and a certificate for 63 
their continuing professional development (CPD).  64 
Academic detailing training 65 
 D.O.R. received formal training in academic detailing by attending a two-day workshop at the 66 
National Resource Center for Academic Detailing (NaRCAD) in Boston, USA in May 2016. 67 
The workshop provided a critical foundation for the role as an academic detailer. It included 68 
sessions on the case for academic detailing and evidence-based medicine, planning a visit, use 69 
of educational materials and role plays.  70 
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Academic detailing materials  71 
For the academic detailing sessions, materials developed by the Alosa Foundation were used. 72 
The Alosa Foundation in Boston is a non-profit organization and is independent of the 73 
pharmaceutical industry. It produces educational materials and decision making tools for 74 
Academic Detailers, and provides training on academic detailing internationally. The Alosa 75 
Foundation granted the authors permission to use their educational materials for this study. The 76 
printed materials consist of evidence-based information on the prevalence of urinary 77 
incontinence, an overview of the pharmacological and non-pharmacological interventions, cost 78 
of drugs to treat the condition, and key messages.  79 
Choice of topic 80 
Prior to commencing GP recruitment, D.O.R. met with three GPs to discuss an intervention 81 
topic. The topic of urinary incontinence was chosen for the academic detailing intervention by 82 
GPs because they highlighted that it was a topic not discussed regularly among themselves, 83 
and currently their only source of information is provided by pharmaceutical drug 84 
representatives.  85 
Piloting the intervention 86 
The academic detailing intervention was piloted with three academic GPs in May 2016 before 87 
the study was commenced. The GPs reported that they were very satisfied with this overall 88 
educational approach. The topic delivered and the educational materials used during the visit 89 
were also described as being very beneficial and relevant. 90 
Delivery of the intervention 91 
The intervention was delivered face-to-face with each GP in their practice. D.O.R contacted 92 
the GP’s receptionist in advance to book a 15-minute time slot with each GP for the meeting. 93 
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One of the tenets of academic detailing is to provide evidence based information over a succinct 94 
time period.  95 
During the meeting, D.O.R   provided the following key messages to GPs: (i) increase detection 96 
of and distinguish incontinence type to guide treatment, (ii) identify and rule out reversible 97 
causes of incontinence, (iii) encourage caffeine reduction, pelvic floor muscle training, and 98 
weight loss as first-line treatments, and (iv) judiciously prescribe medications for urgency 99 
symptoms (but not stress incontinence). GPs were encouraged to discuss these key messages 100 
with their patients when they presented for their next GP appointment.  After the meeting, GPs 101 
were given a copy of the printed materials to use as a reference.   102 
The academic detailing intervention was rolled out to participating GPs between June and 103 
September 2016. Supplementary Figure I shows the timeline of the study. 104 
Quantitative method  105 
A before and after analysis of patient medical records was conducted. All patients aged ≥65 106 
years with urinary incontinence treated by participating GPs were included. These patients 107 
were identified by searching GP databases and notes. D.O.R. extracted data from medical 108 
records at five time points: six and three months before the intervention (T-6), (T-3), at the time 109 
of the intervention (T0), and three and six months after the intervention (T3), (T6). For example, 110 
if the intervention was delivered to a GP in June 2016, data extraction and audit of their patient 111 
medical records was performed retrospectively in December 2016 for the following months: 112 
December 2015, March 2016, June 2016, September 2016 and December 2016.  Patients were 113 
identified as having urinary incontinence based on a diagnosis by the GP or referral letters from 114 
consultant urologists. In some cases, prescription drugs (e.g. mirabegron, tolterodine) 115 
identified from medical records were used as proxies to indicate a diagnosis of urinary 116 
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incontinence. An assessment of patient medical records was carried out at five time points in 117 
the study to identify if pelvic floor muscle training was documented.    118 
 119 
The following criteria were applied to the patient data recorded: 120 
LUTS-FORTA criteria 121 
Drugs to treat lower urinary tract symptoms (LUTS) in older people aged ≥65 years are 122 
classified on their appropriateness based on efficacy, safety, and tolerability using the Fit fOR 123 
The Aged (FORTA) criteria. These criteria classify drugs for the treatment of LUTS into four 124 
ordinal categories, A (absolutely: indispensable drug), B (beneficial: drugs with proven 125 
efficacy), C (careful: drugs with questionable efficacy/safety profiles), and D (don’t: avoid in 126 
older people) [13]. 127 
 128 
The Drug Burden Index (DBI) 129 
The DBI measures the cumulative exposure to anticholinergic and sedative medicines in older 130 
people and its impact on physical and cognitive function [14]. For each drug, the DBI ranges 131 
from 0-1, with 0 being no burden, 0.5 being exposure to the minimum daily dose, and upwards 132 
to 1 as the dose is increased exponentially [15]. In this study, the list of drugs with clinically 133 
significant anticholinergic and sedative effects were defined from a composite list developed 134 
from a review by Duran et al. 2013, the Anticholinergic Cognitive Burden (ACB) scale 135 
developed by Boustani et al. 2008, and from a study published by Ailabouni et al. 2017 [16-136 





Anticholinergic Cognitive Burden (ACB) scale  140 
The cumulative effect of taking multiple medicines with anticholinergic properties is defined 141 
as the anticholinergic burden [19]. The ACB scale is based on a systematic literature review of 142 
medicines with known anticholinergic activity. The scale consists of 88 drugs with known 143 
anticholinergic activity and assesses individual drugs that have none, possible, or definite 144 
anticholinergic properties with a score ranging from 0 to 3 [17].  145 
D.O.R. applied the LUTS-FORTA, DBI, and ACB to patient-related data retrieved from the 146 
electronic medical records. For validation purposes, the three types of criteria were applied 147 
independently by a second member of the research team to a random 10% sample of the data.  148 
 149 
Outcomes  150 
The three outcomes of interest were the overall changes in scores of LUTS-FORTA, DBI, and 151 
ACB in the patients.  152 
 153 
Statistical analysis 154 
It is important to note that a feasibility study is not a hypothesis testing study [20]. One of the 155 
key aspects of these studies is that they do not evaluate effectiveness as they are not powered 156 
to do so [21]. The main focus of this study was to assess feasibility of the intervention, and 157 
therefore the data were analysed using descriptive statistics. Continuous variables were 158 
presented as mean with standard deviation (SD) and range, or median with interquartile range 159 




Qualitative method 162 
After the intervention was delivered to participating GPs by D.O.R., focus groups were 163 
conducted with GPs to explore its feasibility and acceptability.  164 
The focus groups were carried out by three researchers (E.H., C.S., and S.B.) between July and 165 
November 2016. A topic guide was developed based on discussion and consensus among all 166 
authors. The topic guide was iteratively refined after each focus group, was transcribed, and 167 
analysed to pursue emerging themes.  168 
All focus groups were anonymised and fully transcribed and saved in QSR International NVivo 169 
Qualitative Data Analysis Software (V.10.22) to facilitate analysis.  Data were analysed using 170 
thematic analysis. This flexible and useful research approach can potentially provide a rich and 171 
detailed account of the data [22].  172 
 173 
Standardised reporting guidelines 174 
The Good Reporting of a Mixed Methods Study (GRAMMS) framework was used to inform 175 




Quantitative results 180 
The characteristics of 154 patients diagnosed with urinary incontinence included in the study 181 
are detailed in Table I. The documentation of pelvic floor muscle training was reported in 15% 182 





LUTS-FORTA score  186 
Figure I shows the number of patients prescribed drugs identified by the LUTS-FORTA criteria 187 
over time. According to the criteria, no patient was prescribed a drug rated in category A 188 
(absolutely: indispensable drug) at any time point. There was an increase in the number of 189 
patients prescribed drugs in category C (careful: drugs with questionable efficacy/safety 190 
profiles), over time, while there was no change in the number of patients prescribed drugs in 191 
category B (beneficial: drugs with proven efficacy) and D (don’t: avoid in older people) over 192 
time. Supplementary Table III shows the drugs that were identified by the LUTS-FORTA 193 
criteria in this study. 194 
Drug Burden Index 195 
Almost 65% (100/154) of patients did not show any change in drug burden over time.  196 
 197 
Anticholinergic cognitive burden (ACB) scale  198 
Thirty-four percent of patients at T-6 months and 31% of patients at T6 months had an ACB 199 
score of 0.  200 
 201 
Qualitative results  202 
Five focus groups were conducted in total (n=14 GPs). The mean number of participants per 203 
focus group was 3 (range 2 to 4). The focus groups ranged from 19 minutes to 48 minutes. The 204 
number of GPs working in a practice ranged from 1 to 7. The characteristics of GPs interviewed 205 






Themes  210 
Theme 1: The Academic detailing experience 211 
Subtheme: Convenience of academic detailing  212 
Participants highlighted the convenience of the academic detailing session being carried out in 213 
their working environment. They welcomed this educational visit being delivered with little 214 
disturbance to their daily practice. They also reported that they are prepared to block out some 215 
of their working time to accommodate this source of evidence-based information. 216 
 217 
This was in contrast to the alternative sources of evidence-based information that are currently 218 
available for GPs, for example: attending conferences, continuing medical education meetings, 219 
or educational events on topics. Participants reported the frustration at not being able to attend 220 
courses of interest due to the demands of their work schedule.  221 
 222 
Subtheme: The interaction between participant and academic detailer 223 
Participants described the interaction between the GP and the academic detailer as being 224 
important to the success of the intervention. They reported that the session worked because it 225 
felt relaxed and free of pressure. This was in contrast to their experience with some 226 
pharmaceutical drug representatives who they described as having an aggressive approach 227 






Subtheme: The educational materials 232 
Participants said they liked the educational materials because they had a clear layout and were 233 
easy to follow. They reported that they valued the succinct nature of the key messages, while 234 
the tables and figures were presented in a straightforward way. 235 
 236 
Subtheme: The topic: Urinary incontinence  237 
The topic of urinary incontinence was agreed by a number of GPs prior to rolling out the study. 238 
Participants reported that this topic was relevant and suitable to general practice. The relevance 239 
of this topic facilitated the delivery of the intervention to GPs.  240 
 241 
Theme 2: Behaviour change 242 
Participants described the likelihood of changing their behaviour in treating patients with 243 
urinary incontinence following the intervention. However, this change in behaviour could be 244 
influenced by environmental resources, such as the availability of primary care 245 
physiotherapists. 246 
 247 
Subtheme: Knowledge gained 248 
Participants were asked if they had gained any knowledge from the intervention. Some 249 
participants of recent medical experience were not aware of the important role that non-250 




For some participants, the intervention served to refresh their knowledge with the topic rather 253 
than gain new knowledge as some of the treatment options may be more commonly used than 254 
others. 255 
Theme 3: Sustainability  256 
Subtheme:  Academic detailing ownership 257 
Participants were asked how this type of educational intervention could be rolled out to a wider 258 
group of GPs in Ireland. Some suggested that it could be affiliated with the Irish College of 259 
General Practitioners (ICGP), the professional and educational body for general practice in 260 
Ireland. The association with this recognised body could enhance the credibility of academic 261 
detailing among GPs. 262 
 263 
Subtheme: Alternative formats of educational material 264 
Participants suggested an online version of the educational material, which would be easier for 265 
them to manage in a setting where print materials over-accumulate or go missing.  266 
 267 
Subtheme: Desire for practice staff involvement 268 
Participants highlighted the importance of incorporating the wider members of the practice 269 
team in the academic detailing sessions. This is especially significant given the expanded role 270 






Subtheme: Future participation 275 
Participants were asked if they would be interested in participating in future academic detailing 276 
studies. All indicated a willingness to do so. 277 
 278 
Discussion 279 
This study used a mixed methods approach to explore the feasibility and acceptability to GPs 280 
of a pharmacist-led academic detailing intervention.   281 
Participants described the possibility of behaviour change following the intervention; however, 282 
this was partly dependent on the availability of primary care resources such as physiotherapists. 283 
In Ireland, public patients are often on a waiting list to attend primary care physiotherapists.  284 
Pelvic floor muscle training is an effective treatment for women with urinary incontinence and 285 
these exercises are often demonstrated by physiotherapists [24]. Therefore, if academic 286 
detailing interventions are successful, then the treatment modalities recommended by academic 287 
detailers need to be resourced. Participants described the educational materials as being high 288 
quality. These materials contain evidence-based information on the prevalence of urinary 289 
incontinence, an overview of the interventions and cost of drugs to treat the condition, and key 290 
messages which may be very beneficial for GPs. However, if this information is not easily 291 
retrievable for GPs then they may not be used as a treatment resource during a patient 292 
consultation [25]. This may have limited the change in prescribing outcomes in the study. 293 
Participants called for these materials to become available as an online resource as they could 294 





Comparison with existing literature 298 
Allen et al. used a mixed methods study (a questionnaire and semi-structured telephone 299 
interviews) to explore family physician perceptions of academic detailing and identified several 300 
factors that encourage its use. They were: the relevance of the topic, the evidence-based 301 
approach adopted, and the educational material used [26]. These findings are similar to those 302 
in our study. The GPs selected the topic of urinary incontinence for the intervention and 303 
described it as relevant. They welcomed the idea of evidence-based information being 304 
presented to them in their practice and they also described the educational materials used as 305 
being of high quality. Soumerai recommends that educational materials should be brief and 306 
clearly presented [27]. For this intervention, all GPs received one visit from the detailer, 307 
however research has indicated that frequent reinforcement visits can optimise behaviour 308 
change [28]. In this study, GPs indicated a willingness to participate in future academic 309 
detailing studies. Hartung et al. and Anthierens et al also reported similar findings [4,25].  310 
The measures of prescribing assessed: the LUTS-FORTA, DBI, and ACB showed minimal or 311 
no change in their scores following the intervention. As a feasibility study, this study was not 312 
conducted with a view to effecting change in prescribing outcomes, rather to see if the 313 
intervention was feasible and acceptable to GPs and whether this preliminary research was 314 
appropriate for successful implementation in subsequent larger studies. Our findings suggest 315 
GPs are open to this type of intervention, and recruitment and follow-up are possible. A larger 316 
study is required to more accurately examine the potential for meaningful change in clinical 317 
care. 318 
The choice of topic for the academic detailing intervention was an important influence on GPs’ 319 
readiness to participate in the study. It was possible that GPs chose urinary incontinence 320 
because of the difficulty in minimising the side-effects with associated treatments e.g. 321 
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anticholinergic effects and the limited availability of pharmacological options. The choice of 322 
urinary incontinence thus addressed GPs’ learning needs but made evaluation of changes in 323 
prescribing difficult as many of the treatment options highlighted to GPs were non-324 
pharmacological. Alternative topics for example, hypertension, atrial fibrillation, opioids in 325 
chronic pain may provide more scope to examine subsequent change in prescribing behaviours. 326 
 327 
Strengths and limitations  328 
To enhance the validity of the quantitative results, a sample of the data were independently 329 
reviewed by two healthcare professionals. The focus groups were arranged with GPs over a 330 
five-month period and this facilitated prolonged engagement with the data.  331 
Although 23 GPs participated in the intervention, only 14 were available to attend the focus 332 
groups. All participating GPs were contacted in advance about the focus groups; however, 333 
some were away on the scheduled date while others who agreed to participate had to cancel at 334 
the last minute due to clinical emergencies or late clinics. One solution to this issue would be 335 
to organise them outside of practice hours e.g. at continuing professional development 336 
meetings. 337 
The findings from this study may be beneficial to other researchers when developing their own 338 
study designs as they may enhance their approach or avoid similar pitfalls [29]. In future 339 
studies, a follow-up visit could be arranged with the GPs after four to six weeks to reinforce 340 
the key messages from the first visit and to identify if they have been successfully 341 
implementing any suggested changes. It would also give the academic detailer an opportunity 342 
to answer any additional questions that the GPs may have. Implementing academic detailing 343 
on a broader scale may benefit from, a “train the trainer” approach. Instructors could train their 344 
colleagues and this would help to build a pool of competent academic detailers. Finally, 345 
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randomized controlled trials that are methodologically robust and have large sample sizes 346 
should be considered [30]. 347 
 348 
Conclusion 349 
This mixed methods study explored the feasibility and acceptability to GPs of a pharmacist-350 
led academic detailing intervention. Overall, participants reported that this evidence-based 351 
approach was beneficial and welcomed further visits. The selection of a relevant topic appeared 352 
to be an important aspect of their positive response. The printed educational materials were 353 
reported as being well-presented and easy to follow, however an online version was preferred. 354 
Our findings provide a useful platform for the evaluation of academic detailing in primary care 355 
on a larger scale.  Further research is needed in a larger population to determine the impact on 356 
patient outcomes and the cost-effectiveness of academic detailing. 357 
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